Toggle navigation
TWunroll
TWunroll
faq
Contact US
#SynBio
Varro Analytics
Varro_Analytics
And set aside antibodies ( $REGN): if $MRNA / $BNTX / @curevac discover mRNA vaccine, it’s just a question of scaling upSequences can be shared freely over the internet, along
Read more
Felix Ashby
felix_ashby
CM Life Sciences $CMLF is a #SPAC still seeking target. I'm long from near NAV because I like the team very much and find the space exciting. Life sciences and
Read more
Ada
adascarrott
Joining in the #NAF2020 #RSCposter session fun! Here is my poster, How to make your E Coli Count, explaining the process of making binary counters using recombinases in the @UofG_DNApeople
Read more
Helena Shomar
HelenaShomar
Happy to share our latest pre-print about how we identified the barriers that prevent FeS enzymes from functioning within non-native hosts.If you're a synthetic biologist tired of your cool FeS
Read more
Simon Barnett
sbarnettARK
Let's discuss a key aspect of vertical integration for diagnostics companies involved in #oncology testing:Synthetic Biology (#SynBio) We think maximum operating leverage will accrue to those companies who have bought,
Read more
Jessica Stark
JessicaCStark
Our portable, in vitro conjugate vaccine expression (iVAX) platform is this week's cover @ScienceAdvances! We developed a #cellfree #synbio technology to address some of the major challenges limiting conjugate vaccine
Read more
Felix Ashby
felix_ashby
I've made a lot of money off of #SPACs and expect it to continue into next year, but am closely watching some risks. I think the larger and more successful
Read more
Professor Oak
Prof_Oak_
Closing the books on 2020 and recording some thoughts for 2021. Themes, picks, SPAC / IPO watchlists to follow. A thread Fundamentally, expect continued mo for bios in 2021
Read more
Simon Barnett
sbarnettARK
The top community questions for tomorrow’s #mARKetUpdate concern our investment thesis around Invitae ($NVTA). I’m going to begin attaching my references () below, as well as some of my previous
Read more
By continuing to use the site, you are consenting to the use of cookies as explained in our
Cookie Policy
to improve your experience.
I agree